YOLFTbeta
ST Pharm Co.Ltd

ST Pharm Co.Ltd

237690 · KQ · Healthcare / Pharmaceuticals

71,700.00KRW-1200.00 (-1.65%)

Price History

Full chart

Market Stats

Previous Close72,900.00
Open73,600.00
Day Range71,500.00 – 75,000.00
52-Week Range84,100.00 – 172,100.00
Volume113.75K
Market Cap1.94T
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.34%
Beta0.91
50-Day Avg98,756.00
200-Day Avg127,967.00

About

ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Geun-Jo Im Ph.D.
  • Employees566
  • HeadquartersMSA Building, Seoul, South Korea, 06194, Korea
  • Websitehttp://www.stpharm.co.kr

Leadership

  • Mr. Geun-Jo Im Ph.D.CEO & Director · b. 1959
  • Dr. Kyeong Eun Jung Ph.D.Sr. MD & GM of Oligo Research Department · b. 1961
  • Mr. Dong-Ryul LeeHead of Management Support Division & Inside Director · b. 1968
  • Mr. Jung-Young SeokMD & Chief of Quality Assurance Office · b. 1961
  • Mr. Soon-Gi JangMD & Banwol 1st Factory Mang. · b. 1968
  • Mr. Seok-Woo ChoiMD & GM of Sales 1st Department · b. 1968
  • Dr. Kyeong-Jin KimResearch Director & Inside Director · b. 1963

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue138.05B200.36B202.80B97.74B93.26B124.11B165.64B249.32B284.99B273.75B331.68B
Growth (%)-+45.13%+1.22%-51.81%-4.59%+33.08%+33.47%+50.52%+14.31%-3.94%+21.16%
Cost of Revenue86.79B107.37B123.02B94.96B94.88B104.12B107.90B160.39B172.88B177.59B195.48B
Gross Profit51.27B92.99B79.78B2.78B-1.63B19.99B57.74B88.93B112.12B96.16B136.20B
Gross Margin37.14%46.41%39.34%2.84%-1.75%16.10%34.86%35.67%39.34%35.13%41.06%
Operating Expense11.37B15.43B18.61B18.43B25.08B38.80B52.17B71.08B78.66B68.61B81.27B
Operating Income39.90B77.56B61.17B-15.65B-26.70B-18.82B5.58B17.85B33.46B27.55B54.93B
Operating Margin28.90%38.71%30.16%-16.01%-28.63%-15.16%3.37%7.16%11.74%10.06%16.56%
EBITDA-------39.71B52.49B76.07B92.64B
EBITDA Margin-------15.93%18.42%27.79%27.93%
Net Income25.19B61.43B45.00B-9.27B-18.53B-12.15B3.31B18.00B19.58B34.71B54.99B
Net Income Margin18.25%30.66%22.19%-9.48%-19.87%-9.79%2.00%7.22%6.87%12.68%16.58%
R&D10.34B8.58B9.66B8.77B15.06B13.20B18.22B26.31B30.45B22.11B23.71B
R&D as % of Total Revenue7.49%4.28%4.76%8.98%16.15%10.64%11.00%10.55%10.68%8.08%7.15%
Interest Expense00000644.58M5.16B2.87B6.11B7.74B4.04B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.52%3.11%1.15%2.14%2.83%1.22%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets232.37B367.78B381.50B345.51B341.08B445.57B498.57B570.65B675.44B721.88B782.57B
Total Liabilities105.04B54.53B30.42B13.94B40.12B150.24B175.59B233.02B288.53B218.88B189.56B
Total Equity110.87B313.24B351.08B331.57B300.96B295.33B322.97B337.63B384.55B503.13B593.44B
Cash11.80B55.20B72.30B47.71B74.66M8.70B27.35B50.20B50.10B63.41B30.55B
Total Debt----15.57B126.03B-----
Net Debt-----87.02B67.25B80.65B138.80B52.07B45.99B

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow35.82B50.78B54.44B10.77B-30.52B-20.93B7.27B7.03B1.30B109.45B13.99B
Investing Cash Flow-33.06B-93.20B-26.33B-26.78B-9.77B-69.07B-8.03B-5.72B-82.39B-86.54B-
Financing Cash Flow6.64B85.20B-9.13B-9.01B5.32B115.93B-115.59M10.81B81.40B-10.95B-
Capital Expenditure22.40B16.03B27.70B27.17B6.22B16.99B51.79B60.66B43.44B83.22B47.29B
Free Cash Flow------38.38B-44.65B-53.63B-42.14B26.23B-33.30B
Dividends Paid1.05B2.95B9.24B9.33B9.33B--9.40B9.40B9.40B10.08B
FCF to OCF-----183.33%-614.16%-762.80%-3245.92%23.96%-238.01%
Dividend Paid to FCF--------17.53%-22.31%35.86%-30.26%

Earnings

Report DateAug 11, 2016Oct 25, 2016Jan 20, 2017Apr 21, 2017Jul 26, 2017Nov 2, 2017Jan 22, 2018May 15, 2018Jul 27, 2018Nov 2, 2018Jan 22, 2019May 3, 2019Aug 5, 2019Oct 30, 2019Feb 12, 2020Apr 29, 2020Jul 23, 2020Nov 2, 2020Jan 25, 2021Apr 28, 2021Jul 28, 2021Oct 28, 2021Feb 24, 2022May 16, 2022Aug 8, 2022Oct 31, 2022Feb 16, 2023Apr 28, 2023Aug 14, 2023Nov 14, 2023Mar 25, 2024May 2, 2024Jul 25, 2024Nov 12, 2024Dec 31, 2024Apr 30, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---576.001162.17798.97731.45300.00707.33587.11------292.00-94.00-107.00298.00-5.00229.00523.00104.0096.09252.72414.12309.48278.89363.00878.21312.95228.54--------
EPS Actual1643.07874.52578.00722.00855.00423.00402.0043.00265.00-357.00-447.00-282.36-164.00-52.25-516.93-220.00157.00-374.00-214.00-269.00287.00402.00-246.00102.00181.00542.00133.00201.0071.00209.00560.00331.0053.00750.00637.7851.79269.18849.001495.11723.00632.74
Surprise---25.35%-26.43%-47.06%-45.04%-85.67%-62.54%-160.81%-----24.66%267.02%-249.53%-171.81%-5640.00%75.55%-147.04%-1.92%88.37%114.47%-67.88%-35.05%-74.54%-42.42%-36.23%5.77%-76.81%--------
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hours-----

Key Statistics & Ratios

Market Cap1.94T
Enterprise Value1.81T
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.92
Price / Book3.03
Revenue (TTM)200.66B
Gross Profit (TTM)55.31B
EBITDA23.45B
Profit Margin5.47%
Operating Margin4.01%
Return on Equity667.34%
Return on Assets0.98%
Shares Outstanding18.66M
Shares Float10.06M
Beta0.91
Dividend Yield0.34%
Dividend Rate0.00
Payout Ratio13.51%

Dividends

20261×
500.00Mar 30, 2026
20241×
500.00Dec 27, 2024
20231×
500.00Dec 27, 2023
20221×
500.00Dec 28, 2022
20211×
500.00Dec 29, 2021
20181×
500.00Dec 27, 2018
20171×
500.00Dec 27, 2017
20161×
500.00Dec 28, 2016